+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


2020 Controlled & Modified Drug Release Summit (San Diego, United States - December 1-3, 2020)

  • ID: 4991339
  • Conference
  • Location: San Diego, United States
  • 3 Days
  • Curtis & Coulter
  • Conference Dates: December 1-3, 2020
until Sep 01st 2020
1 of 3

Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market.

Now in its 7th successful year and on course to be the biggest yet, our popular 2020 Controlled & Modified Drug Release Summit gives you unprecedented access to 50+ of the industry’s leading drug development & delivery experts. Attend and learn from multiple specially curated and unique case study sessions that give you actionable take-home examples to enhance your drug product pipeline. Gather insights into the latest technologies and methods for improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.

This intensive 3-Day program will share innovative controlled and modified drug release strategies that will benefit your current and future product pipelines. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel controlled and modified release strategies, which could speed up time to market and save your organization millions. Can you afford to miss this?

*Extra value: Attend this August and gain complimentary access to the 2020 Peptide Drug Design & Development Summit now in its 4th year! (2 events co-located for the price of 1 registration).

You Will Learn

  • Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
  • Regulatory guidance for modified release dosage forms
  • Advances in ocular delivery
  • Micro and nanoparticle delivery
  • Parenteral routes of administration
  • Topical and transdermal delivery
  • Oral peptide commercialization and delivery
  • Enhancing patient adherence via drug delivery
  • Oral drug formulation and delivery technologies

Improve The Performance Of Your Drug Products

Meet 160+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!

Note: Product cover images may vary from those shown
2 of 3


3 of 3

Tycho Heimbach, PhD
Director, PK Sciences, PBPK and Biopharmaceutics, Novartis

Rakesh Dixit, PhD
Vice President, R&D, Head Biologics Safety Assessment, AstraZeneca

Mohammad Al-Sayah, PhD
Senior Scientist, Drug Product Development, Genentech Inc.

Eric Munson, PhD
Head, Department of Industrial and Physical Pharmacy, Purdue University

Yingkai Liang, PhD
Senior Scientist, Discovery Pharmaceutical Sciences, Merck & Co.

Jae Yoo, PhD
Chief Technology Officer, Aprecia Pharmaceuticals

Scott Shandler, PhD
Founder and CEO, Longevity Biotech

Vincent Ling, PhD
Senior Director, Advanced Technologies, Drug Product Development, Takeda

Di Bei, PhD
Senior Clinical Pharmacologist, Bristol-Myers Squibb

Victor Hruby, PhD
Regents Professor, Department of Chemistry, University of Arizona

Umar Maharoof, PhD
Associate Director, Dosage Form Development, Medimmune

Xiaoling Li, PhD
Associate Dean and Professor, University of the Pacific

John Lambris, PhD
Dr. Ralph and Sallie Weaver Professor of Research Medicine, University of Pennsylvania

Biplop Mitra, PhD
Principal Research Scientist, Drug Product Development, Celgene Corporation

Daniel Skomski, PhD
Senior Scientist, Merck

Shirlynn Chen, PhD
Distinguished Research Fellow, Boehringer Ingelheim

Note: Product cover images may vary from those shown
4 of 3


Kona Kai Resort
1551 Shelter Island Dr
San Diego
CA 92106
United States

Note: Product cover images may vary from those shown